VANCOUVER, BRITISH COLUMBIA -- Aurora Cannabis Inc. ("Aurora" or the "Company") (CSE:ACB)(OTCQB:ACBFF)(FRANKFURT:21P)(WKN:A1C4WM) is pleased to announce that its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., has been granted a license from Health Canada to sell medicinal cannabis pursuant to the Marihuana for Medical Purposes Regulations ("MMPR"). 

Neil Belot, Chief Brand Officer, commented, "People seeking a holistic approach to health and wellness, who believe in medical cannabis and the healing power of nature, can now choose a culture and community minded Licensed Producer which truly understands their needs."

The sales license authorizes Aurora for the sale of medicinal cannabis to patients across the country vaulting it into a leading position within the industry. Aurora's 55,200 square foot indoor production facility in Alberta is capable of producing over 5,400 kg of medicinal-grade cannabis per year. 

Out of all the publicly traded fully licensed producers in Canada, Aurora has the second most licensed indoor production space...